Under the settlement, Abbott will divest the rights and assets for its line of point-of-care blood gas testing systems to Siemens Aktiengelsellschaft and sell its point-of-care cardiac marker testing systems to Quidel Corporation. Abbott will also hand over two Ottawa, Canada-based facilities to Siemens and one San Diego-based facility to Quidel.
Abbott completed its acquisition of Alere in October. The FTC ruled the acquisition would likely hinder competition for these two types of medical devices in a September complaint.
More articles on supply chain:
Prime Healthcare taps HealthTrust for GPO services
Acorda Therapeutics halts Parkinson’s drug trials after 5 patient deaths
Cardinal Health to sell Chinese distribution business to Shanghai Pharma
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
